Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03775200

Organisation Name: COMPASS Pathways

Overal Status: Recruiting

Start Date: January 1, 2019

Last Update: November 25, 2020

Lead Sponsor: COMPASS Pathways

Brief Summary: The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression

Conditions:
  • Treatment Resistant Depression


Total execution time in seconds: 0.20040893554688